ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 125 filers reported holding ATEA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,424 | -79.2% | 14,808 | -74.1% | 0.00% | – |
| Q2 2023 | $213,756 | -45.7% | 57,154 | -51.4% | 0.00% | – |
| Q1 2023 | $393,947 | +16.6% | 117,596 | +67.4% | 0.00% | – |
| Q4 2022 | $337,922 | +144.9% | 70,254 | +188.9% | 0.00% | – |
| Q3 2022 | $138,000 | +2.2% | 24,320 | +28.2% | 0.00% | – |
| Q2 2022 | $135,000 | -95.2% | 18,972 | -95.1% | 0.00% | – |
| Q1 2022 | $2,797,000 | -64.4% | 387,529 | -55.9% | 0.00% | -100.0% |
| Q4 2021 | $7,863,000 | +97.5% | 879,516 | +674.5% | 0.00% | +200.0% |
| Q3 2021 | $3,981,000 | +245.3% | 113,566 | +111.7% | 0.00% | – |
| Q2 2021 | $1,153,000 | – | 53,655 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tyrus Capital S.A.M. | 1,260,000 | $3,780,000 | 35.90% |
| BML Capital Management, LLC | 4,800,000 | $14,400,000 | 13.22% |
| Stonepine Capital Management, LLC | 1,720,000 | $5,160,000 | 1.71% |
| TANG CAPITAL MANAGEMENT LLC | 3,600,000 | $10,800,000 | 1.52% |
| CM Management, LLC | 275,000 | $825,000 | 0.88% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $7,456,914 | 0.83% |
| EcoR1 Capital, LLC | 6,995,861 | $20,987,583 | 0.71% |
| SECTORAL ASSET MANAGEMENT INC | 600,461 | $1,801,383 | 0.35% |
| Newtyn Management, LLC | 400,000 | $1,200,000 | 0.30% |
| Diametric Capital, LP | 200,000 | $600,000 | 0.25% |